Exclusive-Lilly hires CordenPharma to make diabetes drug Mounjaro's active ingredient -source
Eli Lilly has hired Switzerland-based contract drugmaker CordenPharma to produce the active ingredient in its diabetes drug Mounjaro, a source familiar with the matter told Reuters on Thursday. The move to hire CordenPharma comes as the U.S. drugmaker prepares to launch the type 2 diabetes medicine for weight loss in the United States amid exploding demand for obesity drugs.